Indole sulfonamide modulators of progesterone receptors

Details Indole sulfonamide modulators of progesterone receptors Indole sulfonamide modulators of progesterone receptors

2011-04-26

2011-04-26

Shameem, Golam M (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S469000, C548S509000, C514S412000

Reexamination Certificate

active

07932284

ABSTRACT:
Compounds of Formula (I), wherein n is 1 or 2, and R1, R2, R3, R4, R5, R6, R7, and R8 are as defined herein, their preparation, pharmaceutical compositions, and methods of use are disclosed.

REFERENCES:
patent: 5744488 (1998-04-01), Cross et al.
patent: 6015822 (2000-01-01), Brendel et al.
patent: 7105515 (2006-09-01), Merce-Vidal et al.
patent: 7449478 (2008-11-01), Hsieh et al.
patent: 2003/0191124 (2003-10-01), Merce-Vidal et al.
patent: 2003/0195244 (2003-10-01), Hsieh-Pang et al.
patent: 2003/0199689 (2003-10-01), Nazare et al.
patent: 2005/0065202 (2005-03-01), Vidal et al.
patent: 2005/0222201 (2005-10-01), Birkinshaw et al.
patent: 2005/0245485 (2005-11-01), Lanter et al.
patent: 2006/0111427 (2006-05-01), Jiang et al.
patent: 2007/0185161 (2007-08-01), Gavardinas et al.
patent: WO 99/43654 (1999-09-01), None
patent: WO 00/66554 (2000-11-01), None
patent: WO 03/027094 (2003-04-01), None
patent: WO 03/101981 (2003-12-01), None
patent: 2004/019935 (2004-03-01), None
patent: WO 2005/013976 (2005-02-01), None
patent: WO 2005/014543 (2005-02-01), None
patent: WO 2005/092854 (2005-10-01), None
patent: WO 2006/049889 (2006-05-01), None
Dai, et al., “Chemistry of aminophenols. Part 2: A general and efficient synthesis of indoles possessing a nitrogen substituent at the C4, C5, C6 and C7 positions,” Tetrahedron Letters, vol. 43, pp. 7699-7702 (2002).
Liou, et al., “Concise Synthesis and Structure-Activity Relationships of Combretastatin A-4 Analogues, 1-Aroylindoles and 3-Aroylindoles, as Novel Classes of Potent Antitubulin Agents,”J.Med. Chem., 2004, 47, 4247-4257.
Beevers, et al., “Novel indole inhibitors of IMPDH from fragments: Synthesis and initial structure-activity relationships,”Bioorganic & Medicinal Chemistry Letters, 2006, vol. 16, 2539-2542.
Williams, et al., “The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatments in patients with symptomatic uterine leiomyomata,”Human Reproduction, 2007, 1-9.
Sptiz, et al., “Progesterone receptor antagonists and selective progesterone receptor modulators: proven and potential clinical applications.”Expert Rev. Obstet. Gynecol.2(2), 2007.
Mutter, et al., “The spectrum of endometrial pathology induced by progesterone receptor modulators.”Modern Pathology(2008) 21, 591-598.

Affiliated with

Also associated with

Rating

Indole sulfonamide modulators of progesterone receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole sulfonamide modulators of progesterone receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole sulfonamide modulators of progesterone receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2709012